Clinical trials
Phase 2 Angina Pectoris trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 9 |
| Terminated | 4 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amaranth Medical Inc. | 4 |
| Lisata Therapeutics, Inc. | 2 |
| Medispec | 2 |
| North Florida Foundation for Research and Education | 2 |
| Amgen | 1 |
| Barts & The London NHS Trust | 1 |
| Biopure Corporation | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| CellPraxis Bioengenharia Ltda. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina Pectoris | 35 |
| Myocardial Ischemia | 11 |
| Coronary Artery Disease | 9 |
| Myocardial Infarction | 7 |
| Coronary Disease | 4 |
| Angina, Stable | 2 |
| Cardiovascular Diseases | 2 |
| Chest Pain | 2 |
| Heart Failure | 2 |
| Microvascular Angina | 2 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.